Meet our leaders
Chief Executive Officer
An active leader in the pharmaceutical marketplace for more than 20 years, Stuart co-founded QuVa Pharma in 2015 with long-standing business partner Peter Jenkins. Under their leadership, QuVa has experienced consistent year-over-year growth and is still rapidly expanding.
Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Stuart served as President and COO from 2007-2010 and CEO from 2011-2014. He was instrumental in establishing JHP as a leading injectable pharmaceutical company in the United States before selling the business in 2014.
Previously, Stuart was President of Mayne Pharma Americas, a unit of Mayne that was focused on the manufacture, development, and sale of generic injectable pharmaceuticals, primarily into the hospital market. He led the Americas activity through a period of significant growth and established Mayne Pharma USA as a stand-alone business, ultimately building the division into one of the leading generic oncology providers in the United States.
Chief Development Officer
Specializing in global corporate development and finance, Peter has focused on the pharmaceutical marketplace for the last 20+ years of his storied career. He co-founded QuVa Pharma in 2015 with long-standing business partner Stuart Hinchen. Under their leadership, the firm has experienced consistent year-over-year growth and is still rapidly expanding.
Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Peter served as CEO from 2007-2010 and CDO from 2011-2014, increasing JHP’s portfolio through development and manufacturing partnerships. He helped establish JHP as a leading injectable pharmaceutical company before selling the company in 2014.
Previously, Peter served as CDO of Mayne Group and a Director of Mayne Pharma, where he was instrumental in the acquisition of the largest sterile compounding business in the UK and the acquisition and construction of several FDA-approved pharmaceutical manufacturing facilities. During his tenure, he managed business and product development groups in the U.S., Europe, India, and Australia, and was responsible for all corporate development activities.
Chief Financial Officer
As part of QuVa’s executive leadership team, Brett manages the firm’s finances, including planning, forecasting, analysis, and risk management, among other responsibilities. He is a Chartered Accountant (CPA equivalent in Australia) and has 20+ years of finance and operational experience with listed companies across multiple industries including manufacturing, logistics, and healthcare. Prior to joining QuVa, Brett was the CEO and Managing Director of Australia’s largest ophthalmic business. He worked with KPMG for 12 years after graduating from university with a Bachelor of Business.
Brett currently sits on the board of a hospital located on the Gold Coast in Australia.
Having more than 30 years of pharmaceutical experience, David is knowledgeable in cGMPs and specializes in parenteral drug manufacturing, specifically with Quality and Research & Development. Prior to joining QuVa Pharma, David held leadership roles in Quality and Research & Development with Par, JHP Pharmaceuticals, and Hospira supporting the manufacturing of sterile injectables. David has additional leadership experience in quality roles with Johnson & Johnson, Pfizer, Pharmacia, and Upjohn supporting the pharmaceutical manufacturing of API, OTC, and prescription drugs. David has a strong background in operational excellence, driving continuous improvement in processes and people through coaching and training.
Varsha has 25 years of experience in Hospital Management, Home Infusion, Regulatory Affairs, and Clinical Research. Her expertise with inpatient medication management and drug therapy combined with manufacturing and compounding provide clinical leadership to the QuVa team. She is a biologist, chemist, and pharmacist with a PharmD and a PhD and holds multiple Board Certifications.
Varsha is an active member of ASHP and has served in the House of Delegates. Her patient care experience includes Memorial Hermann, Healix, Houston Methodist, and CHI St. Luke’s, and her research experience includes Baylor College of Medicine and UCSF.
Having more than 21 years in the sterile compounding business and 29 years in pharmacy practice, Travis leads QuVa Pharma’s Clinical Services and Pharmacists-in-Charge (PIC) teams, who provide formulation development, stability studies, and clinical information on new/existing formulations. The PICs are also essential in pharmacist oversight of QuVa operations. Additionally, Travis has been instrumental in creating multiple formulation patents for QuVa.
Throughout his storied career in the compounding/outsourcing industry, Travis has served in various roles such as Owner, CEO, President, COO, and VP. Travis led Unique Pharmaceuticals through full remediation and transformation into compliance with the FDA 503B cGMP standards, achieving third-party sterility assurance certification on the facility. He has served on two Texas State Board of Pharmacy Compounding Committees and has been instrumental in advocating for rules and quality-based regulations within the compounding industry. He has also served eight years on the Board of Directors for the Central Texas Children’s Center, a non-profit organization that provides educational, habilitative, and social programs for children with special needs.
Travis earned his Bachelor of Science in Pharmacy from the University of Texas at Austin and his MBA from Baylor University.
With a diverse career spanning five continents, Mike has nearly 40 years of experience in business leadership and diverse technical management in the pharmaceutical industry. At QuVa, Mike focuses on integrating automated solutions and optimizing compounding processes in support of sterile manufacturing and supply chain platforms. His in-depth knowledge of Good Manufacturing Practices and regulatory requirements ensures sustainable, compliant solutions to prevent drug shortages. Mike and his team continually focus on knowledge transfer and process design to optimize, automate, and advance QuVa’s performance levels and output.
As a member of QuVa’s leadership team since inception, Donna Kohut, Vice President of Strategic Projects, applies her 30+ years of experience in pharmaceutical manufacturing to drive key business objectives and implement strategies for continued growth and operational effectiveness. Her storied career has included various positions in Supply Chain, Manufacturing, Quality, and Compliance in organizations both domestic and international, such as Johnson & Johnson, Mayne Pharmaceutical, and independent consulting to drug, medical devices, chemical, and allied heath businesses. Donna’s passion for exceptional service to customers, employees, and the community exemplifies QuVa’s core values and mission.
As QuVa’s Vice President of Legal Affairs, Cyndi oversees compliance, risk management, contract management, and corporate governance. Having more than twenty years’ experience in the health care industry, Cyndi has previously served in general counsel and chief compliance officer roles at publicly traded health care organizations, managed care plans, global medical device companies, and a non-profit academic medical center, Baylor College of Medicine.
Cyndi’s experience also includes Deputy General Counsel for King Abdullah University of Science and Technology in Saudi Arabia, where she assisted in the startup of the country’s first coed graduate-level scientific and engineering university. She currently is on the faculty of Santa Clara University School of Law and is certified in information privacy and health care compliance.
Leading QuVa’s Human Resources Department, Tracey provides partner-level consult to the CEO and leadership team, focusing on building an exceptional workforce of highly engaged and motivated team members. Having more than 30 years’ experience as a thoughtful business leader at large organizations such as Procter & Gamble, Continental Airlines, and Ernst & Young, Tracey is highly accomplished in successful change management, policy development and implementation, leadership development, and recruitment. Also experienced with business direction and strategy, she combines her HR experience with business acumen to identify top talent and foster strong relationships among her business partners
Sales & Commercial Operations
As QuVa’s Vice President of Sales and Commercial Operations, Ray oversees all commercial sales, customer service, and sales operations for the firm. He has deep experience across generic, branded, and 503B pharmaceutical markets and customers that span Hospital & IDN, various clinical specialties, Specialty Pharmacy, Wholesaler & Distributor, Patient and Payor. Having spent more than 20 years of his career in the pharmaceutical industry at large organizations such as Sanofi-Aventis, Baxter Healthcare, and Amerisource Bergen/PharMEDium, Ray has extensive enterprise experience building teams and developing high-performing, go-to-market sales strategies.
Marketing & Corporate Communications
Mike has been in the healthcare field for the last 22 years and has a diverse and extensive commercial background in Sales and Marketing. He joined QuVa in 2017 from having previously led Sales and Marketing organizations at pharmaceutical companies Pfizer, Alexion, and Mylan. He has deep experience across generic, branded, and biosimilar pharmaceutical markets and customers that span Hospital & IDN, Clinic, Specialty Pharmacy, Wholesaler & Distributor, Patient and Payer.
Mike is responsible for leading QuVa Pharma’s corporate, product, and services marketing, as well as internal and external corporate communications.
Transforming the 503B sterile compounding industry
QuVa was established in 2015. Our leadership team has pharma-grade backgrounds with deep expertise in FDA, cGMP, and aseptic manufacturing. They are resolute in the goal of making the 503B compounding industry more safe, efficient and reliable. We saw there was a better way to do business, then we built it, with the right people, processes and facilities.